SIV Env-binding IgGs developed from early infection in both NAb inducers and non-rapid-progressing NAb non-inducers, the latter differing from rapid progressors known to manifest serological failure (Hirsch et al., 2004; Nakane et al., 2013; Figure 1—figure supplement 3A). The gene discussed is ERVW-1; the disease is infection.